Diplôme national de master contrôlé par l'État

Résumé

Objectives: To train the actors of translational research in cardiovascular, metabolism and respiratory physiopathology. Innovate for better care. Read more

Accéder aux sections de la fiche

Details

General information

- Entry:
  • Master 1 : September 2023
  • Master 2 : September 2024
- Duration: 2 years
- Place: Nantes
- Langue: English and French
 

Laboratory

Introduction

The GP InnoCARE is an interdisciplinary training programme that offers a choice of training in experimental research, data analysis or clinical research. InnoCARE brings together students with various backgrounds (scientists, health professionals, engineers, etc.).

This programme benefits from the expertise of research unit and the Clinical Investigation Centre (CIC) of the institut du Thorax. It is based on an integrative and translational vision of cardiovascular, metabolic and respiratory diseases, both in care structures and in the laboratory.

At the institut du Thorax, researchers, engineers, clinicians and clinical research professionals work together to diagnose, understand, prevent and treat these diseases. Throughout the training, InnoCARE students will be formed in the various innovative approaches including genomics, the generation of cellular or animal models for the study of pathologies, the identification of biomarkers and therapeutic targets and the development of innovative treatments.

Cardiovascular, metabolic and respiratory diseases are the major causes of death worldwide. The opportunities for academic, industrial and clinical careers are significant. The professional development of each student is placed at the heart of our GP's educational objective.
 

Why joining the Graduate Programme Innovation for CArdiovascular, metabolic and REspiratory diseases?

Our Graduate Programme rely on student trainings through basic and translational research.

GP InnoCARE scientific areas:

  • Basic and translational research in the following areas
  • Inherited cardiac rhythm diseases
  • Degenerative heart valve diseases and bioprosthesis
  • Chronic and acute heart failure
  • Intracranial aneurysms
  • Atheromatous disease
  • Dyslipidemia, obesity, diabetes
  • Chronobiology
  • Asthma

Innovative approaches and technologies:

  • Genomics: genetics, epigenetics, transcriptomics, molecular medicine;
  • Modelling pathology: induced pluripotent stem cells (iPS), organoids, genome editing/CRISPR cas9, animal models;
  • Integrative phenotyping: high-throughput electrophysiology, multimodal imaging, functional exploration;
  • Bioanalysis: bioinformatics for basic and (pre)clinical research, systems biology;
  • Biomarker identification and new treatments: multiomic approaches, (photo) pharmacology, biotherapies.

International mobility:

Possibility of international internship from M1

Key partners in Canada:

Key partner in the USA:

Admission

Entry requirement

Academic requirement

Bachelor's degree in Life Sciences

Language requirement:

English B1 or equivalent

Please note: the absence of a test is not a criterion for exclusion, but an interview may be held

Application

Application procedure

Selection: File examination, an additional interview may be requested
Submission period
For students who do not live in France and do not have French nationality:
  • Countries that are part of the Campus France procedure, please note that the inscription will be opened from 1st October to 31st December of the year before the entry year. (Ex: Inscription period from 01/10/2021 to 31/01/2023 for the entry date on 01/09/2023). For more information please access to these links: www.campusfrance.org or Nantes Université – CEF procedure
  • Countries that do not use the Campus France procedure (including EU countries), please follow our VAEE procedure.
For students who have French nationality or resident in France, please follow Candidature en Master
 

Programme

First year of Master

What's next?

Level of education obtained after completion

Bac+5

Competencies acquired

Throughout their studies, GP InnoCARE students will be trained in the following scientific strategies

  • Control preclinical and clinical phenotyping tools
  • Implementation of multi-omics approaches to better characterise the determinants of pathologies
  • Development of animal and cellular models to understand pathophysiology
  • Development of innovative therapies based on advanced approaches in pharmacology and biotherapy
  • Implementation of clinical trials to test these new therapies

Career opportunities

After Master Degree

Further studies

After two years of a Master's degree, you will have the choice of developing your own career or pursuing a research project at PhD level.
Career opportunities after obtained a PhD degree